Showing 2,981 - 3,000 results of 3,102 for search '".gov"', query time: 0.07s Refine Results
  1. 2981

    Collagen turnover biomarkers to predict outcome of patients with biliary cancer by Leonard Kaps, Muhammed A. Genc, Markus Moehler, Stephan Grabbe, Jörn M. Schattenberg, Detlef Schuppan, Rasmus Sund Pedersen, Morten A. Karsdal, Philipp Mildenberger, Annett Maderer, Nicholas Willumsen

    Published 2025-02-01
    “…Trial registration Trial registration number and date of registration NCT00661830 (NCT number) 15 April 2008 Trial registry The complete registry can found under: https://clinicaltrials.gov/study/NCT00661830?tab=table#administrative-information (last accessed 01/2025) Principal investigator and study sponsor Markus Moehler, MD Johannes Gutenberg University Mainz…”
    Get full text
    Article
  2. 2982

    Diabetes distress among immigrants of south Asian descent living in New York City: baseline results from the DREAM randomized control trial by Farhan Mohsin, Laura Wyatt, Hayley Belli, Shahmir Ali, Deborah Onakomaiya, Supriya Misra, Yousra Yusuf, Shinu Mammen, Jennifer Zanowiak, Sarah Hussain, Haroon Zafar, Sahnah Lim, Nadia Islam, Naheed Ahmed

    Published 2025-02-01
    “…Trial registration This study uses baseline data from “Diabetes Management Intervention for South Asians” (NCT03333044), which was registered with clinicaltrials.gov on 6/11/2017.…”
    Get full text
    Article
  3. 2983
  4. 2984
  5. 2985

    Assessment of Bowel Preparation Using Low-Volume Sulphate-Based Preparations in Comparison with Macrogols: A Multicenter, Randomized, Comparative Clinical Study of the 3rd Phase by Evgeny D. Fedorov, Viktor V. Veselov, Sergey V. Kashin, Ekaterina V. Tikhomirova, Alexey V. Veselov, Dmitry V. Zavyalov, Anne Kornowski, Tatyana Gorskaya, Magali Volteau, Thierry Ponchon

    Published 2019-03-01
    “…Despite the higher incidence of nausea in the OSS group, the patients showed significantly higher compliance with the OSS mode as compared to that of Macrogol.This study is registered with the ClinicalTrials.gov Registry of Clinical Trials, No. NCT02321462.…”
    Get full text
    Article
  6. 2986
  7. 2987
  8. 2988
  9. 2989

    Review of the Handbook of Accounting, Accountability and Governance edited by Garry D. Carnegie and Christopher J. Napier by Anna Szychta

    Published 2024-12-01
    “…Accounting scholars, investors and regulatory bodies have developed a wide interest in corporate gov-ernance, especially since the early 1970s (Lai et al., 2023, pp. 28–29). …”
    Get full text
    Article
  10. 2990
  11. 2991
  12. 2992
  13. 2993
  14. 2994
  15. 2995
  16. 2996
  17. 2997

    Feasibility trial of STRONG: A digital intervention to improve nutritional management for individuals with esophageal and gastroesophageal junction cancer by Yu Chen Lin, Jose M. Pimiento, Jeanine Milano, Diane Riccardi, Nakesha Mckinnie, Emma Hume, Olivia Sprow, Sophia Diaz-Carraway, Mara Budnetz, Ryan Hagen, Mohammed Al-Jumayli, Allan Lima Pereira, Andrew J. Sinnamon, Ashwin Somasundaram, Jennifer B. Permuth, Amir Alishahi Tabriz, Kea Turner

    Published 2025-02-01
    “…Clinical trial registration: The Support Through Remote Observation and Nutrition Guidance Program for Gastroesophageal Cancer Patients (STRONG-GEC) study was registered on clinicaltrials.gov (NCT05438940) in June 2022 prior to participant enrollment.…”
    Get full text
    Article
  18. 2998

    The Characteristics and Mortality of Osteoporosis, Osteomyelitis, or Rheumatoid Arthritis in the Diabetes Population: A Retrospective Study by Jin-Feng Huang, Qi-Nan Wu, Xuan-Qi Zheng, Xiao-Lei Sun, Chen-Yu Wu, Xiao-Bing Wang, Chen-Wei Wu, Bin Wang, Xiang-Yang Wang, Michael Bergman, Ai-Min Wu

    Published 2020-01-01
    “…We analyzed osteoporosis, osteomyelitis, and RA deaths associated with diabetes from 1999–2017 using the CDC WONDER system (CDC WONDER; https://wonder.cdc.gov). We used ICD-10 codes to categorize the underlying and contributing causes of death. …”
    Get full text
    Article
  19. 2999

    Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants by Guiqiang Wang, Kexin Zhao, Xiuli Zhao, Yimin Cui, Peng He, Tianzuo Zhang, Yanchao Wang, Rui Shi, Yanhua Li, Qian Wang, Yanping Ren, Zhisong Chen, Xuedan Zhao, Zekang Xie, Yufei Liang, Qingyun Tian, Jing Pan, Chao Zhang, Ying Han, Yuyang Dai, Siyang Ni, Yun Zhang, Xinjie Yang, Yongpan Fu, Dongfang Liu, Jing Li, Miaomiao Zhang, Zhongyu Hu, Liangzhi Xie

    Published 2025-12-01
    “…Reactogenicity was generally mild, with one adverse event of special interest (AESI) and 9 ≥Grade 3 treatment-related adverse events (TRAEs); all recovered within 3 days.Conclusions SCTV01C, when administered as both a primary series and a booster vaccination, exhibited encouraging sustained immunogenicity against both antigen-matched and antigen-mismatched variants, with no significant safety concerns.Clinical trial registration www.clinicaltrials.gov identifier is NCT05148091.…”
    Get full text
    Article
  20. 3000

    Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma by Yu Ri Kang, MD, Hyunkyoung Kim, MS, MPH, Chae Eun Lee, BS, Jae-Woo Jung, MD, PhD, Ji-Yong Moon, MD, PhD, So Young Park, MD, MS, Sae-Hoon Kim, MD, PhD, Min-Suk Yang, MD, PhD, Byung Keun Kim, MD, PhD, Jae-Woo Kwon, MD, PhD, Hye-Kyung Park, MD, PhD, Young-Hee Nam, MD, PhD, Young-Joo Cho, MD, PhD, Taehoon Lee, MD, PhD, Ian M. Adcock, MD, PhD, Pank Bhavsar, MD, PhD, Kian Fan Chung, MD, PhD, Tae-Bum Kim, MD, PhD

    Published 2025-01-01
    “…The study protocol is registered at ClinicalTrials.gov (NCT05164939). Results: The findings underscore strong correlations between serum EDN levels, blood eosinophil counts, and treatment responses, with EDN demonstrating comparable predictive capabilities to blood eosinophil counts to determine treatment responses. …”
    Get full text
    Article